Cargando…

Cardiac Gene Therapy With Relaxin Receptor 1 Overexpression Protects Against Acute Myocardial Infarction

Relaxin is a pleiotropic hormone shown to confer cardioprotection in several preclinical models of cardiac ischemia-reperfusion injury. In the present study, the effects of up-regulating relaxin family peptide receptor 1 (RXFP1) via adeno-associated virus serotype 9 (AAV9) vectors were investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devarakonda, Teja, Mauro, Adolfo G., Cain, Chad, Das, Anindita, Salloum, Fadi N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Preclinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807852/ https://www.ncbi.nlm.nih.gov/pubmed/35128209 http://dx.doi.org/10.1016/j.jacbts.2021.10.012

Ejemplares similares

B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice
por: Devarakonda, Teja, et al.
Publicado: (2020)

Cardioprotection Achieved Through Overexpression of Relaxin Receptors
por: Du, Xiao-Jun
Publicado: (2022)

NADPH Oxidase-4 Driven Cardiac Macrophage Polarization Protects Against Myocardial Infarction–Induced Remodeling
por: Mongue-Din, Heloise, et al.
Publicado: (2017)

Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice
por: Gertz, Zachary M., et al.
Publicado: (2019)

Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK
por: Filippone, Scott M., et al.
Publicado: (2017)

Low-Density Lipoprotein Receptor–Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction
por: Toldo, Stefano, et al.
Publicado: (2017)

Malonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial Infarction
por: Wang, Wei, et al.
Publicado: (2019)

Increased Afterload Following Myocardial Infarction Promotes Conduction-Dependent Arrhythmias That Are Unmasked by Hypokalemia
por: Motloch, Lukas J., et al.
Publicado: (2017)

Connective Tissue Growth Factor Inhibition Enhances Cardiac Repair and Limits Fibrosis After Myocardial Infarction
por: Vainio, Laura E., et al.
Publicado: (2019)

Restoration of Cardiac Function After Myocardial Infarction by Long-Term Activation of the CNS Leptin-Melanocortin System
por: Gava, Fabio N., et al.
Publicado: (2021)

Diffusion Tensor Cardiac Magnetic Resonance Reveals Exosomes From Cardiosphere-Derived Cells Preserve Myocardial Fiber Architecture After Myocardial Infarction
por: Nguyen, Christopher T., et al.
Publicado: (2018)

Brief Myocardial Ischemia Produces Cardiac Troponin I Release and Focal Myocyte Apoptosis in the Absence of Pathological Infarction in Swine
por: Weil, Brian R., et al.
Publicado: (2017)

Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction
por: García, Ricardo A., et al.
Publicado: (2021)

Renal Denervation Decreases Susceptibility to Arrhythmogenic Cardiac Alternans and Ventricular Arrhythmia in a Rat Model of Post-Myocardial Infarction Heart Failure
por: Chang, Sheng-Nan, et al.
Publicado: (2017)

Micro RNA-411 Expression Improves Cardiac Phenotype Following Myocardial Infarction in Mice
por: Nugroho, Ardiansah Bayu, et al.
Publicado: (2022)

Injectable Myocardial Matrix Hydrogel Mitigates Negative Left Ventricular Remodeling in a Chronic Myocardial Infarction Model
por: Diaz, Miranda D., et al.
Publicado: (2021)

Injectable Biomaterials and Myocardial Infarction: Gaining a Toehold in an Unstable Matrix
por: Spinale, Francis G.
Publicado: (2021)

Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction
por: Ali, Muhammad, et al.
Publicado: (2016)

Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signaling
por: Devarakonda, Teja, et al.
Publicado: (2022)

Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction
por: Ishii, Masanobu, et al.
Publicado: (2017)

Cardioprotective Effects of VCP Modulator KUS121 in Murine and Porcine Models of Myocardial Infarction
por: Ide, Yuya, et al.
Publicado: (2019)

Leveraging FPR2 Agonists to Resolve Inflammation and Improve Outcomes Following Myocardial Infarction
por: Koenig, Andrew L., et al.
Publicado: (2021)

Matrix Signaling Subsequent to a Myocardial Infarction: A Proteomic Profile of Tissue Factor Microparticles
por: Akpalu, Derrick, et al.
Publicado: (2017)

Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction
por: Aukrust, Pål, et al.
Publicado: (2021)

Vagal Nerve Stimulation Reduces Ventricular Arrhythmias and Mitigates Adverse Neural Cardiac Remodeling Post–Myocardial Infarction
por: Hadaya, Joseph, et al.
Publicado: (2023)

Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction
por: Louwe, Mieke C., et al.
Publicado: (2020)

Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction
por: George, Marc Jonathan, et al.
Publicado: (2021)

Loss of myocardial protection against myocardial infarction in middle-aged transgenic mice overexpressing cardiac thioredoxin-1
por: D´Annunzio, Verónica, et al.
Publicado: (2016)

A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy
por: Shin, Borami, et al.
Publicado: (2019)

Phosphorylcholine Antibodies Preserve Cardiac Function and Reduce Infarct Size by Attenuating the Post-Ischemic Inflammatory Response
por: Pluijmert, Niek J., et al.
Publicado: (2020)

Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment
por: García, Ricardo A., et al.
Publicado: (2019)

Multiparametric Immunoimaging Maps Inflammatory Signatures in Murine Myocardial Infarction Models
por: Maier, Alexander, et al.
Publicado: (2023)

Cardiac Myosin Binding Protein-C Phosphorylation Mitigates Age-Related Cardiac Dysfunction: Hope for Better Aging?
por: Rosas, Paola C., et al.
Publicado: (2019)

Novel GSK-3β Inhibitor Neopetroside A Protects Against Murine Myocardial Ischemia/Reperfusion Injury
por: Kim, Hyoung Kyu, et al.
Publicado: (2022)

Therapeutics That Promote Sympathetic Reinnervation Modulate the Inflammatory Response After Myocardial Infarction
por: Sepe, Joseph J., et al.
Publicado: (2022)

Adeno-Associated Virus Serotype 9–Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts With Left Ventricular Dysfunction Secondary to a Myocardial Infarction
por: Knezevic, Tijana, et al.
Publicado: (2016)

PDGF-AB Reduces Myofibroblast Differentiation Without Increasing Proliferation After Myocardial Infarction
por: Hume, Robert D., et al.
Publicado: (2023)

Extracellular Matrix Biomaterial Therapy for Myocardial Infarction: New Delivery Route and Immunomodulatory Effects
por: Christman, Karen L.
Publicado: (2023)

Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients
por: Zhao, Xiangshan, et al.
Publicado: (2012)

Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice
por: Mackasey, Martin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_05mbivgk2c6gl5066apv6e6mj6